New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

近段时间，美国FDA药物评价和研究中心（CDER）发布了2024创新药年度报告。数据显示，2024年CDER共批准了50个创新药，超过近五年获批创新药数量的平均水平。其中66%创新药使用了一项或多项加快开发和审评的方法，罕见病用药稳占半壁江山。抗体在 ...

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...

Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia. The recommendation by the EMA's ...

They are affected as a result of impairment in inhibitors such as complement factor H (FH), C1-inhibitor (C1INH), tissue factor pathway inhibitor (TFPI), and alpha-2-macroglobulin (A2M). Moreover, the ...

Department of Critical Care Medicine, The First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China The name of disseminated intravascular coagulation (DIC) and its diagnostic ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

没有更多了 ...

Correspondence to: Prof. M Levin, Department of Paediatrics, Faculty of Medicine, Imperial College of Science, Technology & Medicine, Norfolk Place, London W2 1PG, UK; m.levin{at}ic.ac.uk Neisseria ...

2024年12月中美欧批准上市新药盘点我国批准16款新药上市陈倩统计显示，2024年12月，中国批准上市的新药数量为16款，其中有两款是我国自主研发的新药；美国批准8款新药上市；欧盟批准1款新药上市。

自约翰·桑德考克（John Sandercock）（）研发出串联法布里-珀罗干涉 仪（TFPI）以来，布里渊光散射已广泛用于科学研究。 然而，这种复杂仪器的维护以及与其他实验室设备的同步和协调是一项艰巨的任务[1]。为了应对这些挑战，我们的平台thaTEC：OS与软件 模块 ...

Optimizing Drug Packaging: Strategic Approaches for De-Risking Drug Development ...